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Abstract.	
The	objective	of	the	research	was	to	study	the	peculiarities	of	post-stroke	period	
in	 patients	 with	 metabolic	 syndrome	 (MS),	 functional	 consequences,	 cognitive	
impairment,	 to	 identify	structural	brain	changes	on	 the	basis	of	MRI	results;	 to	perform	
correlation	analysis	between	the	brain	volumetric	test	results	and	cognitive	deficit.		
Materials	 and	 methods.	 The	 study	 involved	 116	 patients,	 aged	 51	 to	 81,	 with	
ischemic	 stroke,	 79	patients	 –	main	 group	 –	during	 the	 early	and	 late	 recovery	periods	
after	 ischemic	stroke	 related	 to	MS.	The	control	group	 included	37	patients	 in	 the	early	
and	 late	 recovery	 periods	 after	 acute	 cerebrovascular	 accident	 (ACVA)	 without	 MS.	 To	
determine	the	functional	consequences	of	ischemic	stroke	after	12	weeks	and	1	year	after	
it,	the	examination	was	conducted	and	the	results	were	evaluated	according	to	modified	
Rankine	 scale	 (MSHR)	 and	 Barthel	 Index	 (BI).	 We	 determined	 patients’	 mortality	 rate	
within	 1	 year	 after	 the	 ischemic	 stroke.	 Their	 condition	 of	 cognitive	 functions	 was	
measured	 according	 to	 MMSE,	 MOSA	 and	 FAB	 scales.	 The	 volume	 of	 cortex	 and	 white	
matter	of	the	cerebral	hemispheres,	temporal	and	frontal	lobes	were	measureed	(cm³)	by	
applying	MRI	scanner	Toshiba	Vantage	Titan	1,5.	Workstation	Vitrea	was	used	for	images	
post-processing.		
Results.	 Patients	 with	 MS	 had	 more	 common	 significant	 signs	 (p<0.05)	 of	
neurological	status	 functional	disorders,	delayed	 recovery	and	disability.	Within	a	year,	
in	 the	 main	 group	 mortality	 rate	 because	 of	 recurrent	 stroke	 was	 5.06%,	 which	 was	
significantly	higher	than	in	the	control	group,	where	the	mortality	rate	was	2.7%.	Within	
a	year,	the	process	of	lost	functions	restoring	according	to	MSHR	occurred	in	both	groups,	
but	 in	 the	 main	 group,	 this	 rate	 was	 significantly	 lower	 in	 comparison	 to	 the	 control	
group.	Patients	with	MS	were	determined	 to	have	a	significant	 impairment	of	cognitive	
functions	according	to	cognitive	scales.	However,	a	year	later	cognitive	performance	did	
not	differ	 significantly	 in	 the	main	and	 control	 groups,	although	 they	declined	 in	both	
groups.	Volumetric	parameters	were	determined:	the	volume	of	cortex	and	white	matter	
of	the	cerebral	hemispheres,	temporal	and	frontal	lobes	(cm³).	Results	obtained:	reduced	
total	volume	of	the	brain,	of	the	temporal	and	frontal	lobes	in	patients	of	the	main	group	
(p<0.05).	 Patients	 of	 both	 study	 groups	 were	 determined	 to	 have	 cognitive	 functions	
impairment	-	reduced	volume	of	 the	cortex	 in	 the	 frontal	and	 temporal	 lobes	according	
to	MMSE	scale.	The	correlation	 index	between	cortex	 indicators	of	 frontal	and	temporal	
lobes	volume	and	the	results	of	cognitive	functions	according	to	MMSE	scale	was:	r	=	0,62	
-	temporal	and	r	=	0,59	frontal	 lobes	 indicators.	Modules	of	correlation	coefficients	were	
within	the	average	strength.		
Conclusions.	Patients	who	have	suffered	from	primary	ischemic	stroke	related	to	
MS	 restored	 their	 lost	 functions	 slower	 and	 the	 mortality	 rate	 among	 them	 was	
significantly	higher	(p<0.05)	within	the	first	year	after	stroke	than	in	patients	without	MS.	
Patients	had	cognitive	deficits	related	to	cortex	atrophy	in	the	frontal	and	temporal	lobes	
after	the	primary	ischemic	stroke.	Atrophy	in	these	areas	of	the	cortex	was	more	distinct	
(p<0.05)	 than	 in	 patients	 without	 MS.	 Positive	 correlation	 relationship	 was	 determined	
between	cognitive	performance	and	the	degree	of	cortex	atrophy	 in	the	frontal	 (r	=	0.59)	
and	temporal	(r	=	0.62)	lobes	of	patients	with	ischemic	stroke	related	to	MS.	
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Problem	statement	and	analysis	of	the	recent	research	
The	high	morbidity,	mortality	and	disability	resulting	from	strokes	have	made	this	problem	
not	only	a	medical	but	also	a	social	one.	Every	year	about	5.5	million	people	die	from	stroke	in	the	
world.	However,	the	stroke	morbidity	and	mortality	vary	widely	depending	on	the	economic	level	
of	 the	country.	On	average	 it	makes	up	200-220	persons	per	100,000	population	 [1,	2].	More	 than	
one	 third	of	 these	cases	are	 fatal,	one	 third	of	patients	 tend	 to	need	care	and	outside	assistance,	
becoming	a	burden	 to	 their	 families	and	 state,	and	not	more	 than	20%	of	 the	patients	 return	 to	
their	usual	daily	activities	they	used	to	do	before	the	disease	[3,	4,	5].	Although	in	recent	years	the	
mortality	rate	from	stroke	tends	to	decrease	in	our	country,	but	it	is	still	almost	twice	higher	than	
the	 rate	 in	 the	developed	countries	 in	Europe	and	where	 it	 is	70-80	cases	per	100,000	population	
[6,7,8].	The	ischemic	stroke	constitutes	80-85%	of	all	acute	cerebrovascular	accidents	(Zozulya	I.S.	
and	co.,	2012).	Only	for	medical	care	of	the	patients’	with	acute	ischemic	stroke	is	spent	from	4	to	
6%	of	the	funds	allocated	to	health	care	in	the	developed	countries	annually.	
All	 the	above	mentioned	 information	causes	 interest	 in	 the	stroke	 risk	 factors	correction,	
treatment	 and	 prevention.	 Today,	 such	 risk	 factors	 as	 stroke,	 hypertension,	 physical	 inactivity,	
obesity,	dyslipidemia,	 smoking	and	combination	of	 them	have	 increased	among	 the	population.	
That	is	why	the	problem	of	metabolic	syndrome	(MS)	comes	to	prominence.	
The	 most	 important	 argument	 for	 studying	 the	 impact	 of	 MS	 on	 the	 origin,	 course	 and	
prognosis	 of	 ischemic	 stroke	 is	 its	 atherogenic	 affect	 leading	 to	 cardiac	 and	 cerebrovascular	
complications	of	atherosclerosis.	Many	studies	have	shown	that	patients	with	MS	have	often	early	
atherosclerosis	signs	of	carotid	and	coronary	arteries.	This	indicates	that	the	causes	of	myocardial	
infarction,	 ischemic	stroke,	peripheral	vascular	disease	have	a	common	origin.	Scientific	 interest	
encouraged	 by	 MS,	 determines	 the	 evolution	 of	 the	 views	 on	 such	 components	 of	 MS	 as	
hypertension,	abdominal-visceral	adiposity,	insulin	resistance	and	diabetes.	These	factors	should	
be	 considered	 as	 a	 generalized	 cardiovascular-metabolic	 disease.	 [9]	 The	 MS	 definition	 of	 ATP	
classification	 -	 III	 National	 Cholesterol	 Education	 Program	 in	 the	 US	 [10]	 is	 widely	 used	 in	 the	
clinical	practice.	
MS	can	be	characterized	as	clinical	and	pathogenic	complex	of	symptoms	associated	with	
multiple	disturbances	of	metabolic	processes,	of	mechanisms	 regulating	endothelial	 function,	of	
blood	 pressure	 homeostasis	 processes	 which	 form	 on	 the	 background	 of	 neurologic,	 of	
immunologic	 and	 endocrine	 dysfunctions	 under	 the	 conditions	 of	 reduced	 tissue	 sensitivity	 to	
insulin	 -	 insulin	 resistance	 and	 systemic	 hyperinsulinemia	 associated	 with	 it.	 Results	 of	
Fremingham	Heart	Study	and	Parisian	Prospective	Project	have	shown	that	hyperinsulinemia	is	an	
independent	 risk	 factor	 for	 atherosclerosis	 but	 insulin-dependent	 diabetes,	 abdominal-visceral	
obesity,	 elevated	 levels	 of	 fibrinogen	 and	 of	 highly	 sensitive	 C-protein	 in	 the	 blood,	 along	 with	
dyslipidemia,	hypertension	and	smoking	are	 the	main	pathogenic	 risk	 factors	 for	cardiovascular	
diseases	[11].		
Among	the	Finnish	population,	the	relationship	between	the	individual	components	of	MS	
and	the	risk	of	primary	stroke	has	been	studied	involving	almost	a	thousand	of	people	for	14	years.	
Abdominal	 obesity	 (waist	 >	 102	 cm	 in	 men	 and	 >	 88	 cm	 in	 women),	 regardless	 of	 the	 other	
components	of	MS,	was	associated	with	an	increased	relative	risk	of	stroke	developing,	1.52	times	
up	(95%	CI,	1.06-2.17,	p<0.05)	[12].	
Numerous	prospective	studies	indicate	that	MS	has	promoted	cardiovascular	morbidity	and	
mortality	 RATE	 in	 recent	 years,	 and	 it	 concerns	 coronary	 heart	 disease	 and	 ischemic	 stroke	 in	
particular	 [Lakka	 H.M.	 et	 al.,	 2002,	 Ford	 E.S.,	 2004;	 McNeil	 A.M.	 et	 al.,	 2005;	 Iso	 H.	 et	 al.,	 2007].	
According	to	S.Cronin	al.	[2009]	MS	increases	the	risk	of	ischemic	stroke	more	than	twice.	With	the	
increasing	number	of	MS	components,	 the	 risk	of	stroke	 is	several	 times	up.	 If	 there	are	 five	MS	
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components	 present	 -	 the	 risk	 increases	 5	 times.	 The	 most	 important	 components	 of	 MS	 are	
hypertension	and	hyperglycemia.	
According	 to	Boden-Albala	B.	et	al.,	 [2008]	3298	patients	who	had	cerebrovascular	disease	
combined	with	components	of	MS	 revealed	 the	 risk	of	stroke	occurrence	by	50%	higher	during	6	
years	of	monitoring.	In	case	of	MS	successful	treatment,	the	risk	of	stroke	occurrence	reduced	by	
19%	on	average	in	men	and	by	30%	in	women	[13].		
Japanese	 scientists	 having	 analyzed	 more	 than	 2,000	 people’s	MRI	 brain	 results	 without	
cardiovascular	and	cerebrovascular	pathology,	found	a	direct,	independent	and	linear	relationship	
between	the	value	of	the	waist	index	and	the	number	of	lacunar	cysts	in	the	brain	[14].	
The	literature	presents	scarce	results	on	clinical	and	neuroimaging	peculiarities	of	ischemic	
stroke	in	patients	with	MS,	on	comparison	of	brain	morphometric	characteristics	and	its	cognitive	
and	functional	consequences.	
The	objective	of	the	research	was	to	study	the	peculiarities	of	post-stroke	period	in	patients	
with	 MS,	 functional	 consequences,	 cognitive	 impairment,	 to	 identify	 structural	 changes	 in	 the	
brain	on	the	basis	of	MRI	results;	to	perform	correlation	analysis	between	the	brain	volumetric	test	
results	and	cognitive	deficit.			
	
Materials	and	methods	of	the	research		
To	determine	the	significance	of	MS	affect	on	the	patients’	early	and	late	recovery	periods	
after	 ischemic	 stroke,	 116	 patients	 were	 examined	 and	 monitored.	 Monitoring	 was	 conducted	
during	 their	 in-patient	 treatment	 in	 the	neurological	department,	 individual	visits,	by	means	of	
mail	survey	and	telephone	interview.	
79	patients,	aged	51	to	81,	were	examined	during	the	early	and	 late	recovery	periods	after	
ischemic	stroke	while	 receiving	 in-patient	 treatment	 in	 the	neurological	department	of	Kyiv	 Сity	
Hospital	№9.	The	control	group	 included	37	patients	during	 their	early	and	 late	 recovery	periods	
after	acute	cerebrovascular	accident	(ACVA)	without	MS.		
To	determine	the	functional	consequences	of	ischemic	stroke,	examination	was	conducted	
after	 12	 weeks	 and	 1	 year	 after	 it.	 Post-stroke	 consequences	 (degree	 of	 disability)	 were	 defined	
according	to	MSHR.	The	degree	of	activities	of	daily	living	and	the	degree	of	dependency	activities	
of	daily	 living	were	evaluated	by	applying	Barthel	 Index	 (BI).	We	determined	patients’	mortality	1	
year	after	ischemic	stroke.		
Patients	 were	 given	 a	 complete	 neurological	 examination	 (complaints,	 medical	 history,	
neurological	status,	examination	of	the	cardiovascular	system,	blood	pressure,	ECG,	blood	glucose	
test,	 anthropometric	 measurements	 were	 taken).	 The	 condition	 of	 cognitive	 function	 was	
measured	by	applying	MMSE,	MOSA	and	FAB	scales.		
To	diagnose	metabolic	syndrome,	IDF	and	АНА	/NHLBI	criteria	were	used	(2005,	modified	in	
2009).	
Total	 cholesterol	 level,	 HDL	 cholesterol	 and	 triglycerides	 were	 determined	 by	 means	 of	
enzymatic	 method,	 both	 LDL	 and	 VLDL	 cholesterol	 levels	 were	 calculated	 by	 the	 conventional	
method.	To	determine	insulin	resistance,	index	HOMA	was	used.	
All	patients	were	performed	MRI	of	the	brain	and	determined	the	extent	of	ischemic	foci.	
The	brain	and	its	liquor	system	of	41	patients	(27	patients	with	MS	-	Group	1	and	14	patients	
without	MS	 -	group	2)	were	assessed	with	 the	help	of	volumetric	method	 (measuring	volume	of	
certain	brain	areas)	with	MRI	scanner	Toshiba	Vantage	Tenitan	1,5.	Workstation	Vitrea	was	used	
for	 images	 post-processing.	 We	 used	 MRI	 sequences:	 T1	 -	 suspended	 images,	 T2	 -	 suspended	
images,	Isotropic,	Flair,	DWI,	T2	*,	FSBB.	We	determined	the	volume	of	cortex	and	white	matter	of	
the	cerebral	hemispheres	(cm³),	of	temporal	and	frontal	lobes.	
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Results	of	the	research	
The	patients’	distribution	in	the	comparison	groups,	based	on	gender	is	provided	in	Table	1.	
	
Table	1	
The	patients’	distribution	based	on	gender	during	early	and	late	recovery	periods	after	ischemic	
stroke	
	 Main	group	(n	79)	 Control	group	(n	37)	
men	 women	 men	 women	
The	number	of	patients	(n)	and	%	 34	(40.6%)	 45	(59.4%)	 17	(45.5%)	 20	(54.5%)	
	
Data	provided	in	table	1	revealed	gender	distribution	in	the	main	and	control	groups,	where	
women	are	dominating.	It	is	likely	due	to	the	facts	that	women	are	more	medically	conscious,	they	
follow	doctors’	prescriptions	more	carefully	and	stick	to	schedules	of	 the	visits,	and	 that	 greater	
number	of	women	participated	in	the	study.		
Post-stroke	 functional	 consequences	 in	 the	 study	 groups	 according	 to	 modified	 Rankine	
scale	(MSHR)	are	provided	in	Table	2.	
	
Table	2	
Post-stroke	functional	consequences	12	weeks	after	CVA	
	 Evaluation	according	to	MSHR,	points	
	 1	point	 2	points	 3	points	 4	points	and	more	
Main	group(n	79)	 16	(20.3%)	 23	(29.1%)	 28*	(35.4%)	 12*	(15.1%)	
Control	group	(n	37)	 11	(29.7%)	 19(51.35%)	 5	(13.5%)	 2	(5.5%)	
*р<0.05	–	in	comparison	to	the	control	group.	
	
Data	provided	in	table	2	prove	that	the	patients	with	MS	had	more	functional	disturbances	
of	neurological	status,	delayed	recovery	and	signs	of	disability.	
The	main	group	included	the	greatest	number	of	patients	with	medium	degree	of	capacity	
loss	 (3	points)	3	months	after	the	disease	onset,	when	the	patients	could	walk	 independently	but	
needed	a	physical,	psychological	or	intellectual	assistance.		
A	large	number	of	patients	with	mild	capacity	loss	(2	points)	composed	the	main	group	as	
well,	the	condition	when	patients	could	serve	themselves,	but	not	as	properly	as	before	the	disease.	
In	addition,	among	patients	with	a	mild	 capacity	 loss	 (1	point)	 there	was	defined	 the	difference	
between	the	main	and	control	group	with	the	reduced	number	of	patients	with	MS.	We	observed	a	
delayed	recovery	in	the	early	period	after	stroke	in	patients	with	MS	in	the	groups	where	evaluation	
of	patients’	condition	corresponded	3	and	4	points	according	MSHR.	
To	evaluate	 recovery	process	after	 ischemic	stroke	objectively	1	year	after	 it,	 the	patients	
with	MS	of	both	groups	were	examined	and	 their	condition	was	assessed	according	 to	MSHR.	At	
the	same	time	the	analysis	of	patients’	mortality	was	made	during	1	year	of	recovery	after	ischemic	
stroke.	The	results	of	the	study	are	provided	in	Tables	3	and	4.	
Data	provided	 in	Table	4	reveal	that	mortality	rate	was	5.06%	 in	the	main	group,	which	 is	
significantly	higher	 than	 in	 the	control	group,	where	 the	 rate	of	mortality	was	2.7%.	All	patients	
died	because	of	recurrent	stroke	(data	about	patients’	injuries,	poisoning	and	other	possible	causes	
of	death	have	not	been	received).	
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Table	3	
Post-stroke	functional	consequences	1	year	after	CVA	
	 Evaluation	according	to	MSHR,	points	
	 1	point	 2	points		 3	points	 4	points	and	more	
Main	group(n	75¹)	 26	(34.7%)*	 24	(32%)	 21*	(28%)	 4	(5.33%)	
Control	group	(n	36¹)	 21	(56.75%)	 10	(27.0%)	 5	(13.5%)	 	
*P<0.05	–	in	comparison	to	the	control	group	
¹During	 1st	 year	 of	 recovery	 after	 ischemic	 stroke,	 the	 number	 of	 patients	 decreased	 in	
comparison	to	their	original	number	due	to	mortality.		
	
Table	4	
Patients’	mortality	during	1st	year	of	recovery	after	ischemic	stroke	
	 The	number	of	patients	(per	cent)	
Main	group	 4	(5.06%)	*		
Control	group	 1	(2.7%)	
*	P<0.05	–	in	comparison	to	the	control	group	
	
Thus,	 the	 data	 provided	 Table	 3	 indicate	 that	 the	 process	 of	 lost	 functions	 restoring	
according	MSHR	occurred	in	both	groups	within	the	previous	year.	The	number	of	patients	with	a	
mild	capacity	loss	(1	point)	increased,	but	their	number	was	significantly	lower	in	the	main	group	
than	 in	the	control	group.	The	number	of	patients	with	MS,	who	had	medium	degree	of	capacity	
loss,	slightly	 increased	due	 to	 their	 improved	condition.	The	number	of	 this	category	of	patients	
decreased	 in	 the	 control	 group	 as	 well	 due	 to	 their	 reduced	 neurological	 deficit	 and	 due	 to	
considering	them	to	be	patients	with	a	mild	capacity	loss.	The	number	of	patients	who	had	medium	
degree	of	capacity	loss	reduced	significantly	in	the	control	group	(3	points).	Almost	all	the	patients	
were	considered	to	have	mild	capacity	loss.	
We	determined	the	dynamics	of	activities	of	daily	 living	according	to	BI	 in	both	main	and	
control	groups	12	weeks	and	1	year	after	ischemic	stroke.	The	data	are	provided	in	Table	№5.	
	
Table	5	
Dynamics	of	activities	of	daily	living	according	to	BI	
	 Barthel	Index	(points)	
12	weeks	after	CVA		
Me	[Q1,Q3]		
	1	year	after	CVA	
Me	[Q1,Q3]	
Main	group	 75[50;70]		 85[65;75]		
Control	group	 85[60;85]		 90[75;95]		
*P<0.05	
	
There	were	more	patients	requiring	assistance	in	the	main	group.	A	year	after	the	disease	
onset	 there	was	determined	 a	decline	of	dependency	on	 the	outside	 assistance	while	using	 the	
toilet	 and	 taking	personal	 care	 in	 both	 groups.	During	 the	primary	 examination,	 the	median	 of	
differences	between	the	main	and	control	groups	was	10	points,	and	after	1	year	the	difference	was	
5	points.	
In	addition	 to	motor	and	 sensory	disturbances	 that	occurred	 in	patients	due	 to	 ischemic	
stroke,	there	was	a	significant	number	of	cognitive	functions	disturbances	that	appeared	to	be	an	
independent	causative	factor	affecting	patients’	social	adaptation	and	quality	of	life	during	the	early	
and	late	recovery	periods.	
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To	determine	the	impact	of	MS	on	the	development	of	patients’	cognitive	and	non	cognitive	
disorders	 during	 their	 early	 and	 late	 recovery	 periods,	 we	 performed	 of	 those	 patients’	
neuropsychological	testing	who	were	able	to	come	to	visit	with	their	care	givers	and	do	tests.	
Table	6	provides	neuropsychological	test	results	according	to	MMSE,	MOCA	and	FAB	scales	
12	weeks	after	the	stroke.		
	
Table	6	
Neuropsychological	test	results	according	to	MMSE,	MOCA	and	FAB	scales	12	weeks	after	the	
stroke	
	 Main	group	 Control	group	
	 Min	 Max	 Me	 Q1	 Q3	 Min	 Max	 Me	 Q1	 Q3	
МOСA		 16	 25	 21.00*	 22.5	 23,5	 19	 27	 23.00*	 21.50	 24.00	
MMSE	 18	 25	 22.00*	 23.25	 24,75	 19	 28	 23.00*	 21.50	 25.00	
FAB	 11	 17	 14.00	 12.5	 15,5	 12	 18	 16	 13.50	 17.50	
*р<0.05	
	
Table	7	provides	neuropsychological	test	results	according	to	MMSE,	MOCA	and	FAB	scales	1	
year	after	the	stroke.		
	
Table	7	
Neuropsychological	test	results	according	to	MMSE,	MOCA	and	FAB	scales	1	year	after	the	stroke	
	 Main	group	 Control	group	
	 Min	 Max	 Me	 Q1	 Q3	 Min	 Max	 Me	 Q1	 Q3	
МOСа		 16	 25	 21.50	 22.5	 23.5	 19	 27	 22.00	 21.50	 24.00	
MMSE	 18	 25	 22.00	 23.25	 24.75	 19	 28	 22.00	 21.50	 25.00	
FAB	 11	 16	 12.00	 12.5	 15.5	 12	 18	 15	 13.50	 17.50	
*р<0.05	
	
Results	 provided	 in	 Tables	 6	 and	 7	 suggest	 that	 the	 patients	 with	 MS	 were	 identified	 to	
demonstrate	 significantly	 worse	 cognitive	 performance	 than	 those	 without	 MS.	 The	 results	
according	to	all	the	three	scales	without	exception	prove	it.	But	a	year	later,	cognitive	parameters	
in	the	main	and	control	groups	did	not	significantly	differ,	although	they	declined	in	both	groups.	
Taking	 into	account	disputable	 test	 results	obtained	after	a	year	of	 the	disease	onset,	we	
analyzed	some	indicators	of	the	brain	structures	and,	above	all,	the	volume	of	white	and	gray	cortex	
substances	of	the	brain	hemispheres,	of	the	frontal	and	temporal	brain	lobes,	of	the	right	and	left	
hippocampus	(сm³).	
The	brain	 and	 its	 liquor	 system	of	 38	patients	 (24	patients	with	MS	 –	main	group	and	14	
patients	without	MS	–	control	group)	were	assessed	with	the	help	of	volumetric	method	(measuring	
volume	of	certain	brain	areas)	with	MRI	scanner	Toshiba	Vantage	Tenitan	1,5.	Workstation	Vitrea	
was	 used	 for	 images	 post-processing.	 We	 used	 MRI	 sequences:	 T1	 -	 suspended	 images,	 T2	 -	
suspended	images,	Isotropic,	Flair,	DWI,	T2	*,	FSBB.		
The	greatest	changes	occurred	 in	 the	 frontal	and	 temporal	brain	 lobes.	 In	 this	 regard,	we	
held	volumetric	measurements	of	the	temporal	and	frontal	brain	lobes.	The	data	are	presented	in	
Table	8.	
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Table	8	
The	volume	of	white	and	gray	(cortex)	substance	of	the	temporal	brain	lobe	(сm³).	
Measurement	area	 Main	group	(n=24)	
Me	(Q1,Q3)	
Control	group	(n=14)	
Me	(Q1,Q3)	
Р	
The	 volume	 of	 gray	 (cortex)	
substance	of	 the	 temporal	brain	
lobe	(см³)	
94.5	[82;107]	*	cm3	
	
	137.5	[115;160]	cm3	
		
	0.05	
The	 volume	 of	 white	 (cortex)	
substance	of	 the	 temporal	brain	
lobe		
99	[82;110]	*	 	135[125;145]		 0.05	
*	Р	<0.05	–	in	comparison	to	the	control	group	
	
Table	9	
The	volume	of	white	and	gray	(cortex)	substance	of	the	frontal	brain	lobe	(сm³).	
Measurement	area	 Main	group	(n=24)	
Me	(Q1,Q3)	
Control	 group	 (n=14)Me	
(Q1,Q3)	
Р	
	The	 volume	 of	 gray	 (cortex)	
substance	 of	 the	 frontal	 brain	
lobe	(см³)	
94.5	[82;107]	*	cm3	
	
	137.5	[115;160]	cm3	
	
	0.05	
The	 volume	 of	 white	 (cortex)	
substance	 of	 the	 frontal	 brain	
lobe		
99	[82;110]	*	 	135[125;145]		 0.05	
*	Р	<0.05	–	in	comparison	to	the	control	group	
	
Figures	1,	2,	3	demonstrate	volumetric	measurements	of	brain	structures.	
The	 cortex	 volume	 of	 frontal	 and	 temporal	 lobes	 as	 well	 as	 cognitive	 impairments	 were	
analyzed	according	to	MMSE	scale.	The	results	are	presented	in	Table	10.	
	
Table	10	
Relationship	between	cognitive	performance	and	the	cortex	volume	of	frontal	and	temporal	lobes	
	 Main	group	(n=24)	
Me	(Q1,Q3)	
Control	group	(n=14)	
Me	(Q1,Q3)	
Volume	of	gray	matter(cortex)	
of	frontal	lobe	(cm3)	
	Me	[Q1Q3]	
126	[82;147]	*	cm3	
	
197.5	[112;240]	cm3		
Volume	of	gray	matter(cortex)	
of	temporal	lobe	(cm3)	
94.5	[82;107]	*	cm3	
	
	137.5	[115;160]	cm3		
	
MMSE	(points)	Me	[Q1Q3]	 23.0*[22.0;	25.0]	 24.5	[23.5;	26.0]	
	*р<0.05-	the	significant	difference	in	comparison	to	control	group	
	
Data	provided	in	Table	10	show	that	the	patients	of	both	study	groups	were	determined	to	
have	 the	 impairment	 of	 cognitive	 performance	 according	 to	 MMSE	 scale	 with	 reduced	 cortex	
volume	 in	 the	 frontal	and	 temporal	 lobes.	The	correlation	between	 the	cortex	volume	of	 frontal	
and	 temporal	 lobes	 and	 the	 results	 of	 cognitive	 performance	 according	 to	 MMSE	 scale	 was	
determined.	 The	 correlation	 index	 was	 r	 =	 0.62	 –	 of	 temporal	 lobe	 and	 r	 =	 0.59	 of	 frontal	 lobe.	
Modules	correlation	coefficients	were	within	the	average	strength.	
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Fig.	1.	Volume	measurements	of	 the	cerebral	cortex,	of	 the	hippocampi	and	of	 the	 lateral	
ventricles(lateral	ventricles	of	brain	hemispheres	are	marked	with	a	blue	colour,	hippocampi	are	
marked	with	a	yellow	colour)	
	
	
	
	
	
	
	
	
	
Fig.	2.	Volume	measurements	of	the	cerebral	cortex	and	of	white	matter	of	the	frontal	brain	
lobe	(cerebral	cortex	of	white	matter	of	the	frontal	brain	lobe	is	marked	with	a	yellow	colour,	white	
matter	of	the	frontal	brain	lobe	is	marked	with	a	pink	colour).Patient	Sh.,	67	years	old,	main	group,	
partial	atrophy	of	cerebral	cortex	of	the	frontal	brain	lobe.	
	
	
	
	
	
	
	
	
	
	
Fig.	3.	Volume	measurements	of	the	frontal	brain	lobe.	Patient	S.,	65	years	old,	control	group.	
	
	
Discussion	of	the	results	
Patients	 with	 MS	 had	 more	 significant	 signs	 of	 neurological	 status	 functional	 disorders,	
delayed	recovery	and	disability12	weeks	and	a	year	after	ischemic	stroke	according	to	MMSE	scale.	
The	obtained	results	prove	that	patients’	with	MS	early	recovery	was	delayed	after	ischemic	stroke.	
A	year	after	ischemic	stroke,	mortality	rate	was	significantly	higher	among	patients	with	MS	than	
in	patients’	group	without	MS.	
According	 to	 the	 information	 provided	 in	 the	 literature,	 more	 than	 80%	 of	 patients	 are	
diagnosed	with	cognitive	disorders,	and	in	one	third	of	cases	they	have	certain	degree	of	dementia	
after	 ischemic	stroke	 [15].	 In	addition,	a	stroke	may	be	complicated	by	 the	development	of	other	
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neuropsychiatric	 disorders	 of	 emotional-affective	 and	 behavioral	 characteristics	 -	 depression,	
anxiety,	apathy.	The	cause	of	post-stroke	cognitive	 impairment	may	be	multiple	 infarction	brain	
damage,	separate	infarction	of	‘strategic’	areas	or	a	combination	of	cerebral	infarction	with	diffuse	
affection	of	cerebral	matter	of	different	origin.	
Patients	 with	 MS	 were	 determined	 to	 have	 a	 significant	 cognitive	 impairment	 in	
comparison	 to	 the	patients	without	MS	 according	 to	 cognitive	measurements	 scales.	But	 1	 year	
later,	the	cognitive	parameters	both	 in	the	main	and	control	groups	did	not	differ	greatly	though	
they	declined	 in	both	of	them.	 It	could	be	connected,	on	the	one	hand,	with	changing	comorbide	
factors	 and	 cofactors	 of	 underlying	 condition.	 For	 example,	 except	 possible	 increase	 in	 waist	 (3	
patients	did	not	have	that	abnormality	when	they	were	included	into	the	control	group),	patients	
had	heterotonia,	hypertriglytceridaemia,	ischemic	coronary	heart	disease,	anxiety	and	depressive	
disorders.	On	 the	other	hand,	 ischemic	stroke	 foci	developing	 in	 the	 ‘strategic’	areas	of	the	brain	
could	 provoke	 cognitive	 impairments.	 In	 addition,	 the	 neurodegenerative	 process	 that	 had	
heterogeneous	genesis,	after	acute	ischemic	stroke	was	associated	with	vascular,	dismetabolic	and	
other	changes	in	the	brain,	and	it	was	not	related	to	MS	cluster.	
The	 correlation	 of	 cognitive	 functions	 (according	 to	 MMSE	 scale)	 and	 changes	 of	 cortex	
matter	 volume	 proved	 that	 after	 primary	 ischemic	 stroke	 related	 to	 MS	 with	 a	 reduced	 	 cortex	
volume	in	the	frontal	and	temporal	lobes,	patients	had	significant	cognitive	deficit.	The	correlation	
index	was:	r	=	0.62	–	temporal	lobe	volume	reduction	and	r	=	0.59	–	frontal	lobe	volume	reduction.	
Modules	of	correlation	coefficients	were	within	the	average	strength.	
Obviously,	increased	apoptosis	in	the	frontal	and	temporal	lobes	contributed	to	the	atrophic	
processes	in	the	cortex	of	these	brain	areas	and	to	cognitive	functions	impairment.	
	
Conclusions	
1. Patients	who	have	suffered	from	primary	ischemic	stroke	related	to	MS,	restored	their	lost	
functions	 slower	 and	 the	 mortality	 rate	 among	 them	 was	 significantly	 higher	 (p<0.05)	
within	the	first	year	after	stroke	than	in	patients	without	MS.	
2. Patients	had	cognitive	deficits	related	 to	cortex	atrophy	 in	 the	 frontal	and	 temporal	 lobes	
after	 the	primary	 ischemic	stroke.	Atrophy	 in	 these	areas	of	 the	cortex	was	more	distinct	
(p<0.05)	than	in	patients	without	MS.	
3. Positive	correlation	 relationship	was	determined	between	cognitive	performance	and	 the	
degree	of	cortex	atrophy	 in	 the	 frontal	 (r	=	0.59)	and	 temporal	 (r	=	0.62)	 lobes	of	patients	
with	ischemic	stroke	related	to	MS.	
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